UnitedHealth price target lowered to $595 from $615 at RBC Capital

RBC Capital lowered the firm’s price target on UnitedHealth to $595 from $615 but keeps an Outperform rating on the shares after its Q3 results. The firm is also cutting its FY25 EPS view by $1.11 to $29.70 and its FY26 view by $1.14 to $33.20 to reflect the “elevated” Medicare coding intensity, which has persisted beyond resumption prior authorization, as well as Medicaid acuity headwinds, though this should be “transitory”, the analyst tells investors in a research note.